本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Denali Therapeutics Inc.

13.15
+0.41003.22%
盘前12.81-0.3400-2.59%06:16 EDT
成交量:121.16万
成交额:1,601.80万
市值:19.10亿
市盈率:-5.12
高:13.66
开:12.59
低:12.31
收:12.74
数据加载中...
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/10

重要事件披露

Form 8-K - Current report
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities